# Clinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain

> **NCT05291975** · NA · COMPLETED · sponsor: **Erchonia Corporation** · enrollment: 64 (actual)

## Conditions studied

- Neuropathy, Diabetic
- Neuropathy;Peripheral
- Neuropathy, Painful

## Interventions

- **DEVICE:** Erchonia® EVRL™
- **DEVICE:** Placebo Laser

## Key facts

- **NCT ID:** NCT05291975
- **Lead sponsor:** Erchonia Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-17
- **Primary completion:** 2024-10-16
- **Final completion:** 2024-12-12
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2025-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05291975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05291975, "Clinical Efficacy and Human Factors Validation Testing of the Erchonia EVRL for Providing Temporary Relief of Diabetic Peripheral Neuropathy Foot Pain". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT05291975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*